Ampliphi Biosciences Corp (APHB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APHB | AMGN | GILD | CELG | BIIB |
| Company | Ampliphi Biosciences Corp | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Biogen Inc |
| Price Information | |||||
| Exchange | NYSE Arca | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.35 | 335.15 | 83.26 | 108.01 | 200.01 |
| High | 0.36 | 338.97 | 83.99 | 108.59 | 200.37 |
| Low | 0.31 | 334.27 | 82.75 | 107.27 | 196.96 |
| Last | 0.32 | 337.38 | 83.94 | 108.24 | 199.36 |
| Change | -0.08 | +1.43 | +0.04 | +0.11 | -2.08 |
| % Change | -20.33% | +0.43% | +0.05% | +0.10% | -1.03% |
| Volume | 4,650,900 | 4,068,200 | 24,925,900 | 191,230,496 | 3,833,500 |
| 20-Day Average Volume | 2,242,835 | 1,855,500 | 7,644,690 | 16,188,930 | 980,680 |
| Previous Close | 0.40 | 335.95 | 83.90 | 108.13 | 201.44 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.33 | 330.23 | 80.47 | 108.17 | 201.40 |
| 20-Day Raw Stochastic | 22.50% | 91.90% | 89.42% | 63.25% | 49.20% |
| 20-Day Relative Strength | 49.90% | 58.76% | 71.95% | 64.69% | 42.93% |
| Weighted Alpha | -42.30 | +27.84 | +18.32 | +46.30 | -22.73 |
| Today's Opinion | 8% Buy | 100% Buy | 88% Buy | 100% Buy | 100% Sell |
| Previous Opinion | 32% Buy | 96% Buy | 88% Buy | 100% Buy | 100% Sell |
| Last Month's Opinion | 16% Sell | 88% Buy | 56% Buy | 100% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -16.34% since 05/02/19 | +1.48% since 09/13/24 | +1.36% since 09/13/24 | -1.97% since 11/13/19 | +1.91% since 09/13/24 |
| Low | 0.31 on 05/09/19 | 331.00 on 09/18/24 | 82.38 on 09/17/24 | 107.27 on 11/20/19 | 194.75 on 09/16/24 |
| High | 0.44 on 05/08/19 | 339.00 on 09/18/24 | 84.65 on 09/19/24 | 110.53 on 11/14/19 | 204.18 on 09/19/24 |
| 1-Month | |||||
| %Chg | +9.17% since 04/09/19 | +2.69% since 08/20/24 | +12.29% since 08/20/24 | +5.14% since 10/18/19 | -2.98% since 08/20/24 |
| Low | 0.28 on 04/22/19 | 319.00 on 09/06/24 | 74.80 on 08/21/24 | 102.40 on 10/21/19 | 192.25 on 09/13/24 |
| High | 0.44 on 05/08/19 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 207.59 on 08/21/24 |
| 3-Month | |||||
| %Chg | +27.16% since 02/08/19 | +8.87% since 06/20/24 | +22.56% since 06/20/24 | +13.63% since 08/20/19 | -11.62% since 06/20/24 |
| Low | 0.24 on 02/12/19 | 306.11 on 07/03/24 | 66.01 on 07/05/24 | 93.41 on 08/23/19 | 192.25 on 09/13/24 |
| High | 0.44 on 05/08/19 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 238.00 on 07/12/24 |
| 6-Month | |||||
| %Chg | +5.97% since 11/09/18 | +23.56% since 03/20/24 | +13.46% since 03/20/24 | +14.14% since 05/20/19 | -8.61% since 03/20/24 |
| Low | 0.15 on 12/18/18 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 89.08 on 07/23/19 | 189.44 on 04/19/24 |
| High | 0.44 on 05/08/19 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 238.00 on 07/12/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 10,640 | 180,982,432 | 104,576,912 | 77,035,920 | 29,026,218 |
| Shares Outstanding, K | 33,469 | 536,435 | 1,245,853 | 711,714 | 145,597 |
| Annual Sales | 0 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,835,600,000 |
| Annual Net Income | -12,110,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 1,161,100,000 |
| Last Quarter Sales | N/A | 8,388,000,000 | 6,954,000,000 | 4,520,000,000 | 2,464,900,000 |
| Last Quarter Net Income | N/A | 746,000,000 | 1,614,000,000 | 1,691,000,000 | 583,600,000 |
| 60-Month Beta | 2.82 | 0.61 | 0.18 | 1.41 | -0.06 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 4.97 on 08/06/24 | 2.01 on 08/08/24 | 2.99 on 10/31/19 | 5.28 on 08/01/24 |
| Latest Earnings Date | 05/21/19 | 10/29/24 | 11/05/24 | 10/31/19 | 11/13/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.06 | 17.85 | 10.99 | 12.39 |